MK-3614

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Hypertension

Phase 1

A Multiple Dose Study of MK-3614 (MK-3614-002)

CompletedNCT01033643

Merck Sharp & Dohme LLCHypertension

Start: 2009-05-27End: 2009-12-09Updated: 2021-05-03

A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)

CompletedNCT01104545

Merck Sharp & Dohme LLCHypertension

Start: 2008-11-01End: 2009-05-01Updated: 2019-08-08